IPOs 2014: Papa Murphy's

IPO Papa Murphy's Holdings, Inc. (FRSH) is a franchisor and operator of a Take 'N' Bake pizza chain selling uncooked pizzas that customers bake at home. Papa Murphy's has a total of 1,418 franchise and company-owned stores (collectively "system-wide stores") as of December 30, 2013. They were recognized by Technomic in 2013 as the #1 chain overall among all restaurants and all food categories, by Nation's Restaurant News in 2013 and 2012 as one of the Top 5 Overall limited service restaurant chains across all food categories, and by Zagat in 2012 as one of the Top 5 Overall fast food chains across all food categories.

Get an advisory report for this company's Initial Public Offering
View this company's prospectus

IPOs 2014: Moelis

IPO Moelis & Company (MC) is a global independent investment bank that provides strategic and financial advice to corporations, governments and financial sponsors. They offer globally integrated financial advisory services across all major industry sectors. Their team of professionals advises clients on critical decisions, including mergers and acquisitions, recapitalizations and restructurings and other corporate finance matters.

Get an advisory report for this company's Initial Public Offering
View this company's prospectus

IPOs 2014: Paycom

IPO Paycom Software, Inc. (PAYC) is a leading provider of a cloud-based human capital management, or HCM, software solution delivered as Software-as-a-Service, or SaaS. They provide functionality and data analytics that businesses use to manage the complete employment life cycle from recruitment to retirement.

Get an advisory report for this company's Initial Public Offering
View this company's prospectus

IPOs 2014: Adamas

IPO Adamas Pharmaceuticals (ADMS) is a specialty pharmaceutical company that focuses on chronic disorders of the central nervous system, or CNS. Adamas is developing ADS-5102 for levodopa induced dyskinesia, and chronic behavioral symptoms associated with traumatic brain injury. Adamas plans to commercialize their wholly owned product candidates, if approved, by developing a specialty CNS sales force to reach high volume prescribing neurologists and psychiatrists in the United States.

Get an advisory report for this company's Initial Public Offering
View this company's prospectus

IPOs 2014: iKang

IPO iKang Healthcare Group Inc. (KANG) is a provider of private preventive healthcare services including disease screening and other services. iKang's customers are primarily corporate customers who contract them to provide medical examination services to their employees and clients and pay for these services at pre-negotiated prices. iKang also directly markets their services to individual customers.

Get an advisory report for this company's Initial Public Offering
View this company's prospectus